Home›Companies›Biotech & Pharma›Kubanda Cryotherapy

Kubanda Cryotherapy, Inc.

Updated Oct 27, 2026·Latest SEC filing Apr 25, 2024·Suggest an edit

About Kubanda Cryotherapy

Kubanda Cryotherapy is a private company based in Baltimore, Maryland. It has reported $1,025,000 raised in three offerings on Form D since April 2021. Its chief executive is Bailey Surtees.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Apr 22, 2024Apr 25, 2024$200,000fully sold1$200KDebt, Options, Securities on exercise, Convertible Note convertible into preferred stockRule 506(b)Form D ↗
Aug 11, 2023Apr 17, 2024$725,000of $2.2M target15$48,333Options, Securities on exercise, Simple Agreement for Future EquityRule 506(b)Form D ↗
Mar 22, 2021Apr 2, 2021$100,000of $450K target2$50,000Options, Securities on exercise, Simple Agreement for Future EquityRule 506(b)Form D ↗
Total, three offerings$1,025,000

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Kubanda Cryotherapy's Form D filed Apr 25, 2024.

BS
Bailey Surtees
Chief Executive Officer and director
YH
Yixin Hu
Executive officer and director

Sources

  1. SECKubanda Cryotherapy, Inc. filing history